Lv51
1090 积分 2024-09-05 加入
Preclinical development of YL205, a novel NaPi2b-targeting antibody-drug conjugate (ADC) with novel topoisomerase I inhibitor-based linker-payload for treatment of solid tumors
1个月前
已关闭
Short Caco-2 model for evaluation of drug permeability: A sodium valerate-assisted approach
2个月前
已完结
New payloads drive next-gen antibody–drug conjugates
2个月前
已完结
皖公网安备34019202002308
